STRATEGIES FOR STUDYING BRAIN DISORDERS

Vol.6 Neurodevelopmental Liabilities in Brain Disease States

Vol.6 Neurodevelopmental Liabilities in Brain Disease States

Editors:Tomás Palomo, Richard J. Beninger, Trevor Archer, Richard M. Kostrzewa

December 2002

Publisher: Editorial CYM, General Oráa, 47, 28006 MADRID

ISBN: 84-921848-9-2

Pages: 762

Congresos

Neurodevelopmental Liabilities in Brain Disease States

Mojácar (Almería)

October 18 - 22 2001

The content of this congress, together with other contributions on the topic, are collected in vol. 6 of the series "Strategies for studying brain disorders".

PROGRAMME

  1. S1. NEUROBIOLOGICAL CONDITIONS ASSOCIATED WITH DISORDER VULNERABILITY
    • David de Wied, The Netherlands. Remembering Bela: a small commemoration of the Bohusian contributions to Behavioural Neuroscience.
    • Barbara Lipska, USA. A Neurodevelopmental Model of Schizophrenia: Neonatal Disconnection of The Hippocampus.
    • Michel Le Moal, France. Neurodevelopmental factors associated with potential for substance abuse and affective disorders.
    • David de Wied, The Netherlands. Role of neuropeptides in the etiology of psychiatric disorders.
    • Rolf Ekman, Sweden. Neurodevelopmental Influence on the Immune System Reflecting Brain Pathology.
    • Herman Van Praag, The Netherlands. Anxiety/Aggression-driven Depression.About the Role of Serotonin and Cortisol in the Pathophysiology of Certain Types of Depression.
    • Jerzy Vetulani, Poland. A possible physiological role for cerebral tetrahydroisoquinolines.
  2. S2. VULNERABILITY FOR SCHIZOPHRENIA: STRUCTURAL, NEUROHUMORAL AND INCIDENTAL FACTORS
    • Robin Murray, UK. Schizophrenia and Bipolar Disorder: Similar Pathogenic Mechanisms but differences in Neurodevelopment.
    • Richard Beninger, Canada. Neonatal Exposure to MK-801: Behavioral Effects in Juvenile and Adult Rats.
    • Vicente Molina, Spain. Functional and Structural Neuroimaging Studies on Recent-Onset Schizophrenia.
    • José Borrell, Spain. Neurovulnerability to immune system alterations during development.
    • Mark Geyer, USA. Developmental markers of psychiatric disorders as identified by sensory gating.
  3. S3. NEURODEVELOPMENTAL LIABILITIES INFLUENCING AFFECTIVE STATES
    • George Robert DeLong, USA. Fluoxetine Response in Young Children with Autistic Spectrum Disorders.
    • Francisco Artigas, Spain. Control of Aminergic Systems by the Medial Prefrontal Cortex. Potential Role in the Etiology of PTSD and Depressive Disorders.
    • Feng Zhou, USA. Deviations in Brain Serotonergic Development.
    • Pedro L. Delgado, USA. Serotonergic neuronal systems and development in health and disease.
    • Seymur Levine, USA. Environmental factors influencing the ontogeny of the HPA-axis.
    • Luis Miguel García Segura, Spain. Brain vulnerability and gonadal hormones.
    • Athina Markou, USA. Neuroadaptations to chronic exposure to drugs of abuse: Relevance to depressive symptomatology seen across diagnostic categories.
  4. S4. THE LIABILITY POTENTIAL OF ABUSE SUBSTANCES
    • Claudio A. Naranjo, Canada. Central Serotonin Dysfunction and Alcohol Dependence.
    • Consuelo Guerri, Spain. Mechanisms Involved in Central Nervous System Dysfunctions Induced by Prenatal Alcohol Exposure.
    • Jose Antonio Ramos, Spain. Exposure to cannabinoids in the development of endogenous cannabinoid system.
    • John Olney, USA. Glutamate and GABA receptor dysfunction in Fetal Alcohol Syndrome.
    • Lars Oreland, Sweden. Risk factors for the neurohumoral alterations underlying personality disturbances.
    • John Harvey, USA. Abnormalities In The Dopamine D1/P38 Mapk/Creb Molecular Cascade Produced By Prenatal Exposure To Cocaine: Behavioral Correlates.
  5. S5. RISK FACTORS AFFECTING VULNERABILITY FOR MOVEMENT
    • Moussa Youdim, Israel. cDNA Micrarray of Early and Late Gene Expressions in Neurodevelopment of MPTP and 6-Hydroxydopamine Induced Dopaminergic Neurodegeneration.
    • Trevor Archer, Sweden. Postnatal Iron Exposure-Induced Neurofunctional Deficits: Experimental Parkinsonism?.
    • Justo García de Yébenes, Spain. Neurotrophic Factors and Parkinson's Disease.
    • Catherine Bennett, USA. Parkinson´s Disease Pathology: Role of a-Synuclein in normal and disease states.
    • Antonio Gil Nagel, Spain. Neurodevelopmental liabilities in epilepsy.
    • Manfred Gerlach, Germany. Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson´s Disease.
  6. S6. THE BALANCE SHEET OF NEURODEVELOPMENTAL LIABILITY
    • Bruce Trapp, USA. Axonal Loss in Multiple Sclerosis.
    • Lourdes Fañanás, Spain. Genetic Variation and the Complex Phenotype of Mental Disorders.
    • Pierre Sokoloff, France. Role of BDNF in Neurodevelopmental and Pharmacological Adaptive Changes of Dopamine Neurotransmission.
    • Peter Riederer, Germany. Developmental factors leading to movement disorders, in particular Parkinson's Disease.
    • Iván Izquierdo, Brazil. Memory Retrieval and its Lasting Consequences.
    • Richard M. Kostrzewa, USA. The destructive propensities of perinatal neurotoxins on brain development and function.

Fundación Cerebro y Mente
c/ General Oraa, 47 - 1º E 28006 Madrid, España
Telf: +34 91 561 1267 Fax: +34 91 564 1817
http://www.cermente.com

Resolución mínima: 1024 x 768. Navegadores recomendados: Google Chrome / Firefox 3.5+ / Internet Explorer 9.0+ / Opera 9.0+ / Safari 3.0+